Y. Sudhakara Babu

Efficacy of Novel Hemagglutinin-Neuraminidase Inhibitors BCX 2798 and BCX 2855 against Human Parainfluenza Viruses In Vitro and In Vivo

Irina V. Alymova, G.L. Taylor, Toru Takimoto et al. · Antimicrobial Agents and Chemotherapy · 2004 · 85 citations · Full text

Medicine, Infectious Diseases, Pharmacology +14

Structures of native and complexed complement factor D: implications of the atypical his57 conformation and self-inhibitory loop in the regulation of specific serine protease activity

Jing Hua, Y. Sudhakara Babu, Dwight Moore et al. · Journal of Molecular Biology · 1998 · 65 citations

Life Sciences, Biochemistry, Molecular Biology +17

The Arthus Reaction in Rodents: Species-Specific Requirement of Complement

Alexander J. Szalai, Stanley B. Digerness, Alok Agrawal et al. · The Journal of Immunology · 2000 · 57 citations

Life Sciences, Immunology, Pathology +17

The Novel Parainfluenza Virus Hemagglutinin-Neuraminidase Inhibitor BCX 2798 Prevents Lethal Synergism between a Paramyxovirus and <i>Streptococcus pneumoniae</i>

Irina V. Alymova, Allen Portner, Toru Takimoto et al. · Antimicrobial Agents and Chemotherapy · 2004 · 46 citations

Veterinary Medicine, Infectious Diseases, Pharmacotherapy +15

Effect of Hemagglutinin-Neuraminidase Inhibitors BCX 2798 and BCX 2855 on Growth and Pathogenicity of Sendai/Human Parainfluenza Type 3 Chimera Virus in Mice

Makiko Watanabe, Vasiliy P. Mishin, Scott A. Brown et al. · Antimicrobial Agents and Chemotherapy · 2009 · 30 citations

Life Sciences, Infectious Diseases, Pharmacotherapy +17